Stanford V regimen: Difference between revisions

Jump to navigation Jump to search
 
(One intermediate revision by the same user not shown)
Line 11: Line 11:
{{button|Mechlorethamine}}
{{button|Mechlorethamine}}


{{button|Doxorubicin hydrochloride}}
{{button|Doxorubicin}}


{{button|Vinblastine}}
{{button|Vinblastine}}
Line 24: Line 24:


==Indications==
==Indications==
*[[Hodgkin lymphoma]]<ref name="pmid19759185">{{cite journal| author=Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A et al.| title=Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. | journal=Ann Oncol | year= 2010 | volume= 21 | issue= 3 | pages= 574-81 | pmid=19759185 | doi=10.1093/annonc/mdp337 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19759185 }} </ref>
*[[Hodgkin's lymphoma]]<ref name="pmid19759185">{{cite journal| author=Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A et al.| title=Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. | journal=Ann Oncol | year= 2010 | volume= 21 | issue= 3 | pages= 574-81 | pmid=19759185 | doi=10.1093/annonc/mdp337 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19759185 }} </ref>


==References==
==References==

Latest revision as of 16:24, 31 March 2015

WikiDoc Resources for Stanford V regimen

Articles

Most recent articles on Stanford V regimen

Most cited articles on Stanford V regimen

Review articles on Stanford V regimen

Articles on Stanford V regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Stanford V regimen

Images of Stanford V regimen

Photos of Stanford V regimen

Podcasts & MP3s on Stanford V regimen

Videos on Stanford V regimen

Evidence Based Medicine

Cochrane Collaboration on Stanford V regimen

Bandolier on Stanford V regimen

TRIP on Stanford V regimen

Clinical Trials

Ongoing Trials on Stanford V regimen at Clinical Trials.gov

Trial results on Stanford V regimen

Clinical Trials on Stanford V regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Stanford V regimen

NICE Guidance on Stanford V regimen

NHS PRODIGY Guidance

FDA on Stanford V regimen

CDC on Stanford V regimen

Books

Books on Stanford V regimen

News

Stanford V regimen in the news

Be alerted to news on Stanford V regimen

News trends on Stanford V regimen

Commentary

Blogs on Stanford V regimen

Definitions

Definitions of Stanford V regimen

Patient Resources / Community

Patient resources on Stanford V regimen

Discussion groups on Stanford V regimen

Patient Handouts on Stanford V regimen

Directions to Hospitals Treating Stanford V regimen

Risk calculators and risk factors for Stanford V regimen

Healthcare Provider Resources

Symptoms of Stanford V regimen

Causes & Risk Factors for Stanford V regimen

Diagnostic studies for Stanford V regimen

Treatment of Stanford V regimen

Continuing Medical Education (CME)

CME Programs on Stanford V regimen

International

Stanford V regimen en Espanol

Stanford V regimen en Francais

Business

Stanford V regimen in the Marketplace

Patents on Stanford V regimen

Experimental / Informatics

List of terms related to Stanford V regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Stanford V; Stanford V Regimen; Stanford V regimen

Overview

Stanford V regimen refers to a chemotherapy regimen consisting of mechlorethamine, doxorubicin hydrochloride, vinblastine, vincristine, bleomycin, etoposide and prednisone, administered on a compressed schedule and used in the treatment of Hodgkin lymphoma; it may be followed by consolidative radiation therapy.[1][2]

Regimen

Mechlorethamine

Doxorubicin

Vinblastine

Vincristine

Bleomycin

Etoposide

Prednisone

Indications

References

  1. 1.0 1.1 Edwards-Bennett SM, Jacks LM, Moskowitz CH, Wu EJ, Zhang Z, Noy A; et al. (2010). "Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience". Ann Oncol. 21 (3): 574–81. doi:10.1093/annonc/mdp337. PMID 19759185.
  2. "NCI Thesaurus".